[go: up one dir, main page]

BRPI0817247A2 - Processo de produção do virus da gripe, aplicação do referido processo, vacina contra a gripe e utilização de ovos de galinha vacinadas contra a gripe - Google Patents

Processo de produção do virus da gripe, aplicação do referido processo, vacina contra a gripe e utilização de ovos de galinha vacinadas contra a gripe

Info

Publication number
BRPI0817247A2
BRPI0817247A2 BRPI0817247-1A BRPI0817247A BRPI0817247A2 BR PI0817247 A2 BRPI0817247 A2 BR PI0817247A2 BR PI0817247 A BRPI0817247 A BR PI0817247A BR PI0817247 A2 BRPI0817247 A2 BR PI0817247A2
Authority
BR
Brazil
Prior art keywords
influenza
application
chicken eggs
virus production
production process
Prior art date
Application number
BRPI0817247-1A
Other languages
English (en)
Inventor
Catherine Gerdil
Catherine Moste
Isabelle Legastelois
Michel Bublot
François-Xavier Le Gros
Original Assignee
Sanofi Pasteur
Merial Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Pasteur, Merial Ltd filed Critical Sanofi Pasteur
Publication of BRPI0817247A2 publication Critical patent/BRPI0817247A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16161—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BRPI0817247-1A 2007-09-26 2008-09-26 Processo de produção do virus da gripe, aplicação do referido processo, vacina contra a gripe e utilização de ovos de galinha vacinadas contra a gripe BRPI0817247A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0757884A FR2921387B1 (fr) 2007-09-26 2007-09-26 Procede de production du virus de la grippe
PCT/FR2008/051730 WO2009050390A2 (fr) 2007-09-26 2008-09-26 Procede de production du virus de la grippe

Publications (1)

Publication Number Publication Date
BRPI0817247A2 true BRPI0817247A2 (pt) 2015-06-16

Family

ID=39146849

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0817247-1A BRPI0817247A2 (pt) 2007-09-26 2008-09-26 Processo de produção do virus da gripe, aplicação do referido processo, vacina contra a gripe e utilização de ovos de galinha vacinadas contra a gripe

Country Status (17)

Country Link
US (2) US7871807B2 (pt)
EP (1) EP2195420B1 (pt)
JP (1) JP5537429B2 (pt)
KR (1) KR101744014B1 (pt)
CN (1) CN101809144B (pt)
AR (1) AR068541A1 (pt)
AU (1) AU2008313576B2 (pt)
BR (1) BRPI0817247A2 (pt)
CA (1) CA2700288C (pt)
ES (1) ES2541551T3 (pt)
FR (1) FR2921387B1 (pt)
IL (1) IL204361A (pt)
MX (1) MX2010003202A (pt)
RU (1) RU2484136C2 (pt)
TW (1) TWI485247B (pt)
WO (1) WO2009050390A2 (pt)
ZA (1) ZA201001480B (pt)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7960139B2 (en) 2007-03-23 2011-06-14 Academia Sinica Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
US8680020B2 (en) 2008-07-15 2014-03-25 Academia Sinica Glycan arrays on PTFE-like aluminum coated glass slides and related methods
US20140205993A1 (en) * 2013-01-18 2014-07-24 Biolex Therapeutics, Inc. Recombinant avian influenza vaccine and uses thereof
US20140205619A1 (en) * 2008-11-28 2014-07-24 Biolex Therapeutics, Inc. Recombinant avian influenza vaccine and uses thereof
WO2010117786A1 (en) 2009-03-30 2010-10-14 Mount Sinai School Of Medicine Of New York University Influenza virus vaccines and uses thereof
AU2010254136B2 (en) 2009-05-26 2016-09-29 Mount Sinai School Of Medicine Monoclonal antibodies against influenza virus generated by cyclical administration and uses thereof
US11377485B2 (en) 2009-12-02 2022-07-05 Academia Sinica Methods for modifying human antibodies by glycan engineering
US10087236B2 (en) 2009-12-02 2018-10-02 Academia Sinica Methods for modifying human antibodies by glycan engineering
KR20120132506A (ko) 2010-02-18 2012-12-05 마운트 시나이 스쿨 오브 메디슨 인플루엔자 바이러스 질환의 예방 및 치료에 사용되는 백신
US9708373B2 (en) 2010-03-30 2017-07-18 Icahn School Of Medicine At Mount Sinai Influenza virus vaccine and uses thereof
US10338069B2 (en) 2010-04-12 2019-07-02 Academia Sinica Glycan arrays for high throughput screening of viruses
CN108164602A (zh) 2011-09-20 2018-06-15 西奈山医学院 流感病毒疫苗及其应用
CN102586194B (zh) * 2011-12-01 2013-08-14 哈药集团生物疫苗有限公司 H9亚型禽流感病毒Vero细胞适应株及其应用
US10130714B2 (en) 2012-04-14 2018-11-20 Academia Sinica Enhanced anti-influenza agents conjugated with anti-inflammatory activity
US9914956B2 (en) 2012-08-18 2018-03-13 Academia Sinica Cell-permeable probes for identification and imaging of sialidases
CN108641002A (zh) 2012-12-18 2018-10-12 西奈山伊坎医学院 流感病毒疫苗及其用途
WO2014159960A1 (en) 2013-03-14 2014-10-02 Icahn School Of Medicine At Mount Sinai Antibodies against influenza virus hemagglutinin and uses thereof
EP3013365B1 (en) 2013-06-26 2019-06-05 Academia Sinica Rm2 antigens and use thereof
US9981030B2 (en) 2013-06-27 2018-05-29 Academia Sinica Glycan conjugates and use thereof
CN105682666B (zh) 2013-09-06 2021-06-01 中央研究院 使用醣脂激活人类iNKT细胞
CN103736088B (zh) * 2013-11-08 2015-07-15 广东大华农动物保健品股份有限公司 一种禽流感h9亚型灭活疫苗及其制备方法和应用
US10150818B2 (en) 2014-01-16 2018-12-11 Academia Sinica Compositions and methods for treatment and detection of cancers
AU2015206370A1 (en) 2014-01-16 2016-07-07 Academia Sinica Compositions and methods for treatment and detection of cancers
EP3129767B1 (en) 2014-03-27 2021-09-01 Academia Sinica Reactive labelling compounds and uses thereof
EP4116329A1 (en) 2014-05-27 2023-01-11 Academia Sinica Anti-her2 glycoantibodies and uses thereof
CA2950577A1 (en) 2014-05-27 2015-12-03 Academia Sinica Fucosidase from bacteroides and methods using the same
CA2950415A1 (en) 2014-05-27 2015-12-03 Academia Sinica Anti-cd20 glycoantibodies and uses thereof
US10118969B2 (en) 2014-05-27 2018-11-06 Academia Sinica Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
WO2015184001A1 (en) 2014-05-28 2015-12-03 Academia Sinica Anti-tnf-alpha glycoantibodies and uses thereof
EP3191500A4 (en) 2014-09-08 2018-04-11 Academia Sinica HUMAN iNKT CELL ACTIVATION USING GLYCOLIPIDS
US9975965B2 (en) 2015-01-16 2018-05-22 Academia Sinica Compositions and methods for treatment and detection of cancers
US10495645B2 (en) 2015-01-16 2019-12-03 Academia Sinica Cancer markers and methods of use thereof
JP2018504412A (ja) 2015-01-23 2018-02-15 アイカーン スクール オブ メディシン アット マウント サイナイ インフルエンザウイルスワクチン接種レジメン
KR102691114B1 (ko) 2015-01-24 2024-08-01 아카데미아 시니카 신규한 글리칸 콘주게이트 및 이를 사용하는 방법
CN109195996A (zh) 2016-03-08 2019-01-11 中央研究院 N-聚醣及其阵列的模组化合成方法
US11266734B2 (en) 2016-06-15 2022-03-08 Icahn School Of Medicine At Mount Sinai Influenza virus hemagglutinin proteins and uses thereof
KR101879936B1 (ko) * 2016-06-17 2018-07-19 건국대학교 산학협력단 신규한 조류 인플루엔자 h5n9 재조합 바이러스 및 이를 포함하는 백신 조성물
EP3500594A4 (en) 2016-08-22 2020-03-11 Cho Pharma Inc. ANTIBODIES, BINDING FRAGMENTS AND METHOD FOR USE
JOP20190088A1 (ar) * 2016-10-21 2019-04-21 Us Agriculture نواقل مؤتلفة للتعبير عن مولدات مضاد فيروس انفلونزا الطيور و استخداماتها
CN108653724B (zh) * 2017-04-01 2020-11-27 普莱柯生物工程股份有限公司 一种用于预防禽减蛋综合征的疫苗组合物、及其制备方法和应用
CA3058652A1 (en) 2017-04-07 2018-10-11 Icahn School Of Medicine At Mount Sinai Anti-influenza b virus neuraminidase antibodies and uses thereof
JP7084627B2 (ja) * 2018-06-06 2022-06-15 株式会社マナＨｓコーポレーション ウイルス感染症予防用組成物
WO2019246363A1 (en) 2018-06-21 2019-12-26 Icahn School Of Medicine At Mount Sinai Mosaic influenza virus hemagglutinin polypeptides and uses thereof
JP7754490B2 (ja) * 2019-11-29 2025-10-15 学校法人関西医科大学 アジュバント組成物
CN114184797B (zh) * 2021-12-06 2024-06-14 辽宁成大生物股份有限公司 一种流感病毒裂解疫苗单价原液血凝素的检测方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1535543A1 (ru) * 1988-04-05 1990-01-15 Всесоюзный научно-исследовательский институт гриппа Способ получени гриппозного диагностикума
RU2080124C1 (ru) * 1995-10-19 1997-05-27 Санкт-Петербургский научно-исследовательский институт вакцин и сывороток Способ получения живой гриппозной вакцины
EP0848956A1 (en) 1996-12-17 1998-06-24 Dimminaco Ag/Sa/Ltd. In ovo vaccination against Newcastle Disease
US6682754B2 (en) * 1999-11-24 2004-01-27 Willmar Poultry Company, Inc. Ovo delivery of an immunogen containing implant
DE10133664A1 (de) * 2001-07-11 2003-02-06 Henkel Kgaa Verfahren zur Untersuchung von dermalen Klebstoffabrissen
RU2290205C1 (ru) * 2005-09-13 2006-12-27 Федеральное государственное унитарное предприятие "Научно-производственное объединение по медицинским иммунологическим препаратам "МИКРОГЕН" Министерства здравоохранения Российской Федерации Способ получения живой вакцины для профилактики гриппа

Also Published As

Publication number Publication date
FR2921387A1 (fr) 2009-03-27
CN101809144B (zh) 2013-12-25
TWI485247B (zh) 2015-05-21
KR101744014B1 (ko) 2017-07-04
US7871807B2 (en) 2011-01-18
JP2010539918A (ja) 2010-12-24
EP2195420A2 (fr) 2010-06-16
EP2195420B1 (fr) 2015-04-08
RU2010116187A (ru) 2011-11-10
CA2700288C (en) 2019-11-12
RU2484136C2 (ru) 2013-06-10
IL204361A (en) 2013-06-27
AU2008313576A1 (en) 2009-04-23
JP5537429B2 (ja) 2014-07-02
FR2921387B1 (fr) 2012-04-20
WO2009050390A2 (fr) 2009-04-23
CN101809144A (zh) 2010-08-18
CA2700288A1 (en) 2009-04-23
ES2541551T3 (es) 2015-07-21
US20090081255A1 (en) 2009-03-26
AR068541A1 (es) 2009-11-18
TW200923093A (en) 2009-06-01
WO2009050390A3 (fr) 2009-06-11
AU2008313576B2 (en) 2014-01-23
MX2010003202A (es) 2010-04-09
US20110212129A1 (en) 2011-09-01
KR20100090241A (ko) 2010-08-13
ZA201001480B (en) 2011-05-25

Similar Documents

Publication Publication Date Title
BRPI0817247A2 (pt) Processo de produção do virus da gripe, aplicação do referido processo, vacina contra a gripe e utilização de ovos de galinha vacinadas contra a gripe
BRPI0716536A2 (pt) produÇço de vacinas de vÍrus influenza, sem a utilizaÇço de ovos
IL186611A0 (en) Vaccine against pandemic strains of influenza viruses
BRPI0910820A2 (pt) processo de preparação de sílica precipitada, sílica precipitada, e, utilização de uma sílica
BRPI0813307A2 (pt) Composição imunogênica, vacina, e, processo para fabricar a vacina
HUE043952T2 (hu) Módosított influenzavírus vakcinahatékonyság monitorozására és javítására
KR101790354B9 (ko) 인플루엔자 바이러스 ｈ3ｎ2를 중화시킬 수 있는 인간 결합 분자 및 그것의 용도
PL2211901T5 (pl) Szczepienie wieloma kladami wirusa grypy H5
IL203869A (en) Method for the manufcture of a preparation comprising virus or viral antigens and various aspects related thereto, uses thereof and a split virus vaccine preparation obtained by the method
EP2010210A4 (en) VACCINE AGAINST BIRD FLUID AND METHOD OF APPLICATION THEREFOR
EP2968523A4 (en) INFLUENZA NUCLEIC ACID MOLECULES AND VACCINES MANUFACTURED THEREOF
EP2486791A4 (en) PROTEIN VACCINE PREVENTED FROM TRANSGENIC PLANTS AGAINST HIGH DENSITY PATHOGENIC BIRD VEGETABLE VIRUSES AND MANUFACTURING METHOD THEREFOR
BRPI0807597A2 (pt) Composição farmacêutica, e, método para tratar infecção por vírus da influenza
IL213189A (en) Vaccine comprising avian influenza antigen, method of vaccinating an animal therewith, dna encoding the antigen and uses thereof
BRPI1011224A2 (pt) vacina contra vírus da dengue inativado com adjuvante livre de alumínio
EP2525818A4 (en) IMMUNOGENEOUS INFLUENZA COMPOSITION
ZA200809056B (en) Influenza virus vaccine
EA201400235A1 (ru) Вакцины против гриппа на основе н5
BRPI0822098A2 (pt) Componente para uma vacina contra malária, vacina para malária, processo para a preparação do componente, uso do componente, e, método de tratar um paciente suscetível às infecções por plasmodium
BRPI1014436A2 (pt) composto, processo de preparação de um composto, intermediário, composições farmacêuticas, e, utilização de um composto.
BR112013010830A2 (pt) vacina inovadoras contra o vírus da influenza pandêmica a/h1n1
ZA201106852B (en) A method to prepare inactivated vaccine for h9n2 sub-type avian influenza and product
EP2716752A4 (en) RECOMBINANT DOG INFLUENZA VIRUS, MANUFACTURING METHOD AND APPLICATION THEREOF
EP2368899B8 (en) Avian influenza vaccine
BRPI1014435A2 (pt) composto, processo de preparação de um composto, composições farmacêuticas, e, utilização de um composto.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL